SPIN4 and nasopharyngeal carcinoma: Since SPIN4 acts as a transcriptional coactivator and can bind H3K4me3 to promote gene transcription, targeting SPIN4 and H3K4me3 is feasible and represents a promising therapeutic strategy for NPC patients.